Friday, May 31, 2024

TRICHLOROACETIC ACID (METABOLITES OF PERCHLORETHYLENE AND/OR TRICHLORETHYLENE), URINE

Description, Sample, Method and Reference values Modification

Test code: 883
Mnemonic code: Does not apply

Effective update from 10/06/2024




PREVIOUS

NEW

Description: TRICHLOROACETIC ACID (METABOLITES OF PERCHLORETHYLENE AND/OR TRICHLORETHYLENE), URINE

Sample: URINE

Method: High Performance Liquid Chromatography


Reference Values
People exposed to PERCHLOROETHYLENE
FJL (At the end of the workweek): Up to 3.5 mg/L
People exposed to trichlorethylene
FJL (At the end of the workweek): Up to 15.0 mg/L
* Fuente: Valores Bibliograficos
     
         
     
      Version of Test: 4
     


Description: TRICHLOROACETIC ACID, URINE


Sample: END WORKING DAY URINE

Method: Gas Chromatography/Electron Capture Detector (ECD)

Reference Values
VLB (INSST) at the end of the working day: Less than 15 mg/L
BEI (ACGIH) at the end of the working day: Less than 15 mg/L
Limit of quantification: Lees than 1 mg/L



    Version of Test: 5
     

   Find the record of the test by clicking here

MYELIN BASIC PROTEIN , CSF

Reference values Modification

Test code: 2004
Mnemonic code: PBMI

Effective update from 10/06/2024




PREVIOUS

NEW
        
      Less than 4.0 ng/mL
     
     
      Version of Test: 2
     

        
      Less than 5.5 ng/mL   
         
     
      Version of Test: 3
     

   Find the record of the test by clicking here

Thursday, May 30, 2024

VARICELLA ZOSTER IgA ANTIBODIES, SERUM

Test reactivation

Test code: 7662
Mnemonic code: VZA

Effective update from 30/05/2024


   Find the record of the test by clicking here

VARICELLA ZOSTER IgG and IgM ANTIBODIES, CSF

Tests Reactivation

Test code: 4275, 4276
Mnemonic code: VZMCR, VZGCR

Effective update from 30/05/2024



                                   Find the record of the test by clicking here

FREE PHENYTOIN, SERUM

Method Modification

Test code: 1930
Mnemonic code: FENLISU

Effective update from 10/06/2024




PREVIOUS

NEW
        
      High Performance Liquid Chromatography (HPLC)
     
     
      Version of Test: 12
     

        
         
      Liquid Chromatography/Mass Spectrometry (LCMS)   
     
      Version of Test: 13
     

   Find the record of the test by clicking here

Furosemide, serum

Method Modification

Test code: 3480
Mnemonic code: FUROS

Effective update from 10/06/2024




PREVIOUS

NEW
        
      High Performance Liquid Chromatography (HPLC)
     
 
    
      Version of Test: 3
     

        
      Liquid Chromatography/Mass Spectrometry (LCMS)  
         
     
      Version of Test: 4
     

   Find the record of the test by clicking here

HLA-B5701 genotype (susceptibility to Abacavir), total blood

Description, Method, Result Format and Reference values Modification

Test code: 3467
Mnemonic code: B5701

Effective update from 10/06/2024




PREVIOUS

NEW

Description: HLA-B5701 genotype (susceptibility to Abacavir), total blood


Method: Real-Time PCR


Result format:  R1  Result



Reference Values:
Negative


Technique: DNA extraction from whole blood and subsequent amplification by real-time PCR (CE-IVD commercial method) of the alleles of the HLA-B*57:01 group associated with a hypersensitivity reaction to abacavir, and of a fragment of the HBB (ß-globin) gene used as an internal positive control.































Version of Test: 4
     


Description: B5701 (HLA-B*57:01 ALLELE), WHOLE BLOOD


Method: Multiplex PCR/Real-Time PCR


Result format:  R1  Sample
                R2  Result


Reference Values:
Interpretation
Abacavir is a drug that is generally used in combination with others to treat HIV infection. It acts as a reverse transcriptase inhibitor and, although it may present side effects, it is generally well tolerated. However, serious hypersensitivity reactions with symptoms of liver damage and lactic acidosis, which can be life-threatening, have been reported.
Hypersensitivity to abacavir is strongly associated with HLA-B*57:01 allele, an HLA-B gene polymorphism present in around 3% of European population. Consequently, it is recommended to determine the presence/absence of this allele prior to starting treatment since abacavir hypersensitivity is prone to late diagnosis, when symptoms have already appeared, and treatment is more torpid.
This report should be evaluated by a specialist in the context of all available clinical and family information in conjunction with other laboratory findings. Genetic counselling is recommended.

Test method
DNA extraction followed by real-time PCR amplification (CE-IVD commercial method) of  HLA-B*57:01 allele group, associated with abacavir hypersensitivity reaction, and of an HBB gene fragment (β-globin) as internal positive control

Test limitations
Variants other than those studied are not analyzed.
Normal/polymorphic genomic variation in the patient may interfere with variant detection in the sample.

References
Cameron P. U. et al. Abacavir. (2021). Kucers’ the Use of Antibiotics. Seventh Edition 3773–3800 
Mallal, S. et al. (2002). The Lancet 359, 727–732 
Saag, M. S. et al. (2008). Clinical Infectious Diseases 46, 1111–1118 
Quiros-Roldan, E. et al. (2020). Pharmacogenetics and Genomics 167–174 
Mallal, S. et al. (2008). N Engl J Med 358, 568–579


Version of Test: 5




   Find the record of the test by clicking here

WILMS TUMOR · WT1 · MLPA

New Test in NOÛS Catalog

Test Code: 10053

Sample:
Whole blood - EDTA (5 ml)
Conservation:
Refrigerated
Method:
Multiplex Ligation-dependent Probe Amplification-MLPA
Set Up Days:
Daily
Delivery term:
22 days

    Find the record of the test by clicking here

LINK INDEX PARAMETERS

Description, Report and Reference values Modification

Test code: 3190
Mnemonic code: Does not apply

Effective update from 10/06/2024




PREVIOUS

NEW
LINK INDEX PARAMETERS

R1- IgG CSF
R2- Albumin serum
R3- IgG serum
R4- Albumin CSF

        
IgG CSF: Less than 3.40 mg/dL
Albumin Serum: 35.00 - 52.00 g/L
IgG Serum: 295.00 - 1719.00 mg/dL
Albumin CSF: Less than 35.00 mg/dL
Link Index: Less than 0.80
     
     
      Version of Test: 8
     
TIBBLING-LINK INDEX

R1- IgG serum
R2- Albumin serum
R3- IgG CSF
R4- Albumin CSF

IgG Serum:      295.00 - 1719.00 mg/dL
Albumin Serum:  35.00 - 52.00 g/L  
IgG CSF:        Less than 3.40 mg/dL
Albumin CSF:    Less than 35.00 mg/dL
Link Index:     Less than 0.80
     
     
      Version of Test: 9
     


   Find the record of the test by clicking here

Wednesday, May 29, 2024

OROPOUCHE ANTIBODIES IgG + IgM, SERUM

New Test in NOÛS Catalog

Test Code: 10052

Sample:
Serum (1 ml)
Conservation:
Refrigerated
Method:
Indirect fluorescent antibody
Set Up Days:
Daily
Delivery term:
15 days

    Find the record of the test by clicking here

BIOTINIDASE ACTIVITY, PLASMA

Reference values Modification

Test code: 2709
Mnemonic code: BIOT

Effective update from 10/06/2024




PREVIOUS

NEW
        
      5.3 - 12.2 nmol/mL/min
      LoQ: 0.5 nmol/mL/min
     
     
      Version of Test: 14
     

        
      7.8 – 13.1 nmol/mL/min   
         
         
     
      Version of Test: 15
     

   Find the record of the test by clicking here

BARTONELLA (Rochalimaea) HENSELAE(CAT SCRATCH FEVER) IgM ANTIBODIES, SERUM

Test reactivation and Reference values Modification

Test code: 2498
Mnemonic code: BAHM

Effective update from 10/06/2024




PREVIOUS

NEW
        
      Negative: Titer less than 1/5.
      *Source: Insert
     
      Version of Test: 7
     

        
      Negative: Titer less than 1/12   
      *Source: Insert     
     
      Version of Test: 8
     

   Find the record of the test by clicking here

BARTONELLA HENSELAE (Rochalimaea) (CAT SCRATCH FEVER) ANTIBODIES, SERUM

Test reactivation and Reference values Modification

Test code: 2497
Mnemonic code: BAHG

Effective update from 10/06/2024




PREVIOUS

NEW
        
      Negative: Titer less than 1/100
      *Source: Insert
     
      Version of Test: 7
     

        
      Negative: Titer less than 1/512   
      *Source: Insert   
     
      Version of Test: 8
     

   Find the record of the test by clicking here

Monday, May 27, 2024

DICHLOROMETHANE, URINE

Reference values Modification

Test code: 6004
Mnemonic code: DICL

Effective update from 03/06/2024




PREVIOUS

NEW
        
      Non-exposed personnel: Less than 0.3 mg/L

      


     
      Version of Test: 6
     

        
  Exposure to Dichloromethane
  VLB (INSST) in end-of-shift urine: Less than 0.3 mg/L
  BEI (ACGIH) in end-of-shift urine: Less than 0.3 mg/L   
  Limit of Quantification: Less than 0.05 mg/L  
   
  Version of Test: 7
     


   Find the record of the test by clicking here

Thursday, May 23, 2024

PORPHYRINS , URINE

Reference values Modification

Test code: 5194
Mnemonic code: PFRA

Effective update from 10/06/2024




PREVIOUS

NEW
        
      COPROPORPHYRINS I : Less than 25 µg/24H
      COPROPORPHYRINS III : Less than 75 µg/24H
      UROPORPHYRINS (OCTOCARBOXYL) : Less than 25 µg/24H
      PENTACARBOXYLPORPHYRINS : Less than 5 µg/24H
      HEXACARBOXYLPORPHYRINS : Less than 2 µg/24H
      HEPTACARBOXYLPORPHYRINS : Less than 5 µg/24H
     
     




          Version of Test: 6
       


    COPROPORPHYRIN I  : 2 - 24 µg/24H
    COPROPORPHYRIN III: 10 - 65 Âµg/24H
    UROPORPHYRINS (OCTOCARBOXYL): 3 - 24 µg/24H
    PENTACARBOXYLPORPHYRINS: Less than 4 µg/24H
    HEXACARBOXYLPORPHYRINS: Less than 2 µg/24H
    HEPTACARBOXYLPORPHYRINS: Less than 3 µg/24H
    *Source: Thomas L: Labor & Diagnose 2020,2020. www.labor-und-diagnose-2020.de, accessed October 14, 2021.          
         
         
     
         Version of Test: 7
     


   Find the record of the test by clicking here